title: Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity.
authors.affiliation: Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
authors.forename: Xiu-Juan
authors.initials: XJ
authors.lastname: Li
authors.affiliation: Department of Medical Equipment, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
authors.forename: Xiao-Peng
authors.initials: XP
authors.lastname: Yang
authors.affiliation: Department of Ophthalmology, Children's Hospital of Zhengzhou, Zhengzhou, Henan 450052, China.
authors.forename: Shuang
authors.initials: S
authors.lastname: Sun
authors.affiliation: Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
authors.forename: Xiao-Bei
authors.initials: XB
authors.lastname: Lyu
authors.affiliation: Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
authors.forename: Heng
authors.initials: H
authors.lastname: Jia
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D058449:Intravitreal Injections / Q000379:methods*; D000069579:Ranibizumab / Q000008:administration & dosage* / Q000627:therapeutic use*; D012178:Retinopathy of Prematurity / Q000188:drug therapy* / Q000601:surgery; D012189:Retrospective Studies
chemical_list: D020533:Angiogenesis Inhibitors; D000069579:Ranibizumab